|
|
||||||||
CUTTING EDGE |






*
Max Planck Institute for Infection Biology, Berlin, Germany;
Department of Immunology, University Clinics, Ulm, Germany; and
La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
| Abstract |
|---|
|
|
|---|
at the onset of
listerial infection. These findings point to a regulatory role of
CD1-reactive cells in the immune response against
listeriosis. | Introduction |
|---|
|
|
|---|
With the availability of mAbs against mCD1 molecules, it is now possible to study CD1 expression during infection and to gain further insights into their functional properties. In our approach to these issues, we infected mice with Listeria and examined CD1 expression and the effects on listeriosis after treatment with anti-CD1-specific mAbs.
| Materials and Methods |
|---|
|
|
|---|
C57BL/6 mice were kept under specific pathogen-free conditions at the animal facilities of the University of Ulm, and experiments were performed with 8- to 10-wk-old mice of either sex. Animals were age and sex-matched in a given experiment.
Abs
Spleen cells were stained with the following Abs: anti-L3T4
(CT-CD4; Medac, Hamburg, Germany), anti-Lyt2 (CT-CD8
; Medac),
anti-CD3 (clone 145-2c11; a kind gift from J. Bluestone),
anti-Ly5 (B220) (clone RA3-6B2; Medac), anti-TCR-
ß (clone
H57-597; a kind gift from R. Kubo), anti-TCR-
(clone GL-3;
kindly provided by L. Lefrancois), anti-NK1.1 (clone PK136;
American Type Culture Collection, Manassas, VA), anti-CD11c (clone
HL-3; PharMingen, San Diego, CA), anti-MAC1 (clone M1/70, American
Type Culture Collection), anti-Fc-receptor (clone 2.4G2; kindly
provided by M. Lamers), anti-H2Db (clone B22249; kindly
provided by G. Hämmerling), anti-H2I-Ab (clone
AF6-120.1; PharMingen), and anti-CD1 (clone 1B1; PharMingen). Abs
were either PE or FITC conjugated or biotinylated. Biotinylated Abs
were detected with streptavidin-RED670 (Life Technologies, Grand
Island, NY).
For in vivo experiments, anti-CD1-producing hybridomas 1B1 (rat IgG2b) or 20H2 (rat IgG1; a kind gift from A. Bendelac (13)) were cultured, and mAb were purified on a protein G-Sepharose affinity column (Pharmacia, Piscataway, NJ) before use.
Flow cytometric analysis
Staining of cell surface markers was performed as described elsewhere (7). Cells were analyzed in a FACScan (Becton Dickinson, Mountain View. CA) using Cell Quest software (Becton Dickinson). Both anti-CD1 mAb, 1B1 and 20H2, were tested for interference and no cross-blocking was detected (data not shown).
Bacterial infection of mice
Mice were infected i.v. with 5 x 103 L.
monocytogenes. For anti-CD1 mAb treatment, 0.5 mg of either
1B1 or 20H2 mAb were injected i.p. simultaneously with L.
monocytogenes. Rat
-globulin (11 mg/ml; Jackson ImmunoResearch,
West Grove, PA) was used as control Ab. Survival was monitored over 14
days after infection with 8 x 103 L.
monocytogenes and mAb treatment.
Determination of cytokines
Single-cell suspensions of spleen cells from L.
monocytogenes-infected mice, either rat
-globulin or
anti-CD1 (20H2) treated, were prepared at different time points
postinfection (p.i.), restimulated, and culture supernatants were
screened for cytokine production, i.e., IFN-
, IL-12, and TNF by
double-sandwich ELISA as described (14). TGF-ß2 determination was
performed by a TGF-ß2-ELISA kit (Promega, Madison, WI). TGF-ß1
measurements resulted in high media background, prohibiting conclusive
results.
Statistics
Significant differences in survival time were analyzed by a log-rank test for curve comparison using a Graph Pad Prism computer program (GraphPad Software; Becton Dickinson). In all cases, p < 0.05 was considered to be significantly different.
| Results |
|---|
|
|
|---|
Constitutive surface expression of mCD1 molecules on almost all
lymphocytes as well as on monocytes and macrophages has been described
(7). We followed mCD1 cell surface expression in mice during
listeriosis (day 0 to day 7 p.i.) by staining distinct cell
populations with mAb against CD1. In naive mice, B220+
cells, CD3+ cells, CD11c+ cells,
MAC-1+ cells, and NK1.1+ cells expressed CD1
molecules on their cell surface (Fig. 1
).
CD1 expression was increased primarily on APC, as well as on NK cells
during listeriosis (Fig. 2
A).
In contrast, CD1 expression on T cells remained virtually stable
throughout infection. Our findings that CD1 expression was elevated
mainly on APC during infection could mean that CD1 molecules play a
role in Ag presentation during listeriosis.
|
|
Mice were infected with Listeria and treated
simultaneously with control Ab or anti-CD1 mAb 20H2 or 1B1. The in
vivo treatment with these mAb did not affect CD1 expression on spleen
cells of infected mice (Fig. 2
B). CD1 expression in both
groups was not significantly different (Students t test)
despite a trend toward reduced CD1 expression in anti-CD1-treated
animals. Moreover, in vivo treatment with mAb did not deplete
corresponding cell populations, because cell numbers in both groups
were comparable (data not shown). The 
T cell population was also
not changed (59% CD1+ 
cells in rat
-globulin-treated mice vs 62% CD1+ 
cells in
anti-CD1-treated mice at day 1 p.i. and 76% vs 80% at day
3 p.i., respectively). Variations in the NK T cell population
could not be determined, because total numbers in spleen were <1%.
Listeriosis was ameliorated in anti-CD1-treated mice (Fig. 3
). We conclude that CD1 molecules
interact with cells that influence the course of listeriosis. The most
likely explanation would be that this is due to changes in the early
cytokine pattern.
|
Proinflammatory cytokines, in particular TNF-
, the Th1
cell-promoting cytokine IL-12, and the Th1 cytokine IFN-
are crucial
for protection against listeriosis, while Th2 cytokines counteract
protective immunity (1, 8). The regulatory cytokine TGF-ß has an
ambiguous role in listeriosis, although TGF-ß often curtails ongoing
immune responses (15, 16). Fig. 4
reveals
that during listeriosis IFN-
, IL-12, and TNF secretion were
increased in anti-CD1-treated mice as compared with controls. In
contrast, TGF-ß2 production was decreased and this was not due to
changes in cell numbers of single-cell populations. We conclude that
diminished TGF-ß2 secretion favored production of a protective
cytokine response to Listeria, thus ameliorating
listeriosis.
|
| Discussion |
|---|
|
|
|---|
In listeriosis, protection is mediated by Th1 cytokine-secreting cells, while Th2 cytokines play a subordinate role. The role of TGF-ß in listeriosis is so far insufficiently understood (15). In several infections, protective immune responses are regulated by TGF-ß, which controls both Th1 and Th2 cytokine secretion, and is therefore referred to as a Th3 cytokine (18, 19). TGF-ß is produced by multiple cells of the leukocyte lineage, including lymphocytes, macrophages, and dendritic cells, and it acts in an autocrine and paracrine mode (16). TGF-ß impairs the capacity of macrophages to produce IL-12 and to express CD40, and thus inhibits IL-12-mediated Th1 responses (20). In contrast, TGF-ß limits immunopathological consequences of infection, and hence may play a role in the termination of the anti-infective immune response after pathogen eradication (18).
In anti-CD1 mAb-treated mice, increased secretion of the protective
cytokines TNF, IL-12, and IFN-
was paralleled by decreased TGF-ß2
production soon after listerial infection. This could mean that TGF-ß
produced by the innate immune system controls Th1 cytokine production.
Thus a decrease in TGF-ß could lead to elevated Th1 production and
therefore better protection. Most likely candidates that could regulate
anti-listerial immune responses include NK T cells and 
T
cells (1). CD1 restriction has been demonstrated for the majority of NK
T cells (9). Upon primary activation by CD1 molecules, these cells
produce IL-4 and IFN-
, and CD1 deficiency results in impaired IL-4
production (10, 11, 21). NK T cells also secrete TGF-ß and express
immunosuppressive activities (22). Another potential target are 
T cells. Like NK T cells, 
T cells can produce TGF-ß (23). They
participate in protection against listeriosis, but so far no
restriction element for 
T cells in murine listeriosis has been
identified (1). Therefore, further investigation of CD1-specific
ligands of microbial origin recognized by murine T cells is necessary.
Independent of the exact cellular source of TGF-ß, our data reveal
that anti-CD1 mAb treatment interferes with TGF-ß2 production and
up-regulates secretion of TNF, IL-12, and IFN-
. We assume that the
up-regulation of protective cytokines was a consequence of TGF-ß
down-modulation. As a result, anti-CD1 mAb treatment ameliorated
listeriosis. Thus, our report provides first evidence for a regulatory
role of CD1 in antilisterial immunity.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Current address: Dr. Christoph H. Ladel, c/o Glaxo Wellcome S.p.A., Microbiology Department, Via A. Fleming 4, 37100 Verona, Italia. ![]()
3 Address correspondence and reprints to Dr. Stefan H. E. Kaufmann, Max Planck Institute for Infection Biology, Monbijoustrasse 2, D-10117 Berlin, Germany. E-mail address: ![]()
4 Abbreviations used in this paper: mCD1, murine CD1; p.i., postinfection. ![]()
Received for publication December 1, 1998. Accepted for publication April 9, 1999.
| References |
|---|
|
|
|---|
ß+ T cells. Nature 372:691.[Medline]
treatment ameliorate disease by a bacterial Th1 pathogen in IFN-
receptor deficient mice. J. Immunol. 157:4746.[Abstract]
upon activation by anti-CD3 or CD1. J. Immunol. 159:2240.
TCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo. J. Immunol. 157:574.[Abstract]
This article has been cited by other articles:
![]() |
C. Wiethe, A. Debus, M. Mohrs, A. Steinkasserer, M. Lutz, and A. Gessner Dendritic Cell Differentiation State and Their Interaction with NKT Cells Determine Th1/Th2 Differentiation in the Murine Model of Leishmania major Infection J. Immunol., April 1, 2008; 180(7): 4371 - 4381. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raghuraman, Y. Geng, and C.-R. Wang IFN-beta-Mediated Up-Regulation of CD1d in Bacteria-Infected APCs J. Immunol., December 1, 2006; 177(11): 7841 - 7848. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Emoto, I. Yoshizawa, Y. Emoto, M. Miamoto, R. Hurwitz, and S. H. E. Kaufmann Rapid Development of a Gamma Interferon-Secreting Glycolipid/CD1d-Specific V{alpha}14+ NK1.1- T-Cell Subset after Bacterial Infection. Infect. Immun., October 1, 2006; 74(10): 5903 - 5913. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ranson, S. Bregenholt, A. Lehuen, O. Gaillot, M. C. Leite-de-Moraes, A. Herbelin, P. Berche, and J. P. Di Santo Invariant V{alpha}14+ NKT Cells Participate in the Early Response to Enteric Listeria monocytogenes Infection J. Immunol., July 15, 2005; 175(2): 1137 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Duthie, M. Kahn, M. White, R. P. Kapur, and S. J. Kahn Critical Proinflammatory and Anti-Inflammatory Functions of Different Subsets of CD1d-Restricted Natural Killer T Cells during Trypanosoma cruzi Infection Infect. Immun., January 1, 2005; 73(1): 181 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Blackstock and J. W. Murphy Age-Related Resistance of C57BL/6 Mice to Cryptococcus neoformans Is Dependent on Maturation of NKT Cells Infect. Immun., September 1, 2004; 72(9): 5175 - 5180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Teige, I. Teige, S. Lavasani, R. Bockermann, E. Mondoc, R. Holmdahl, and S. Issazadeh-Navikas CD1-Dependent Regulation of Chronic Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis J. Immunol., January 1, 2004; 172(1): 186 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skold and S. M. Behar Role of CD1d-Restricted NKT Cells in Microbial Immunity Infect. Immun., October 1, 2003; 71(10): 5447 - 5455. [Full Text] [PDF] |
||||
![]() |
C. Faveeuw, V. Angeli, J. Fontaine, C. Maliszewski, A. Capron, L. Van Kaer, M. Moser, M. Capron, and F. Trottein Antigen Presentation by CD1d Contributes to the Amplification of Th2 Responses to Schistosoma mansoni Glycoconjugates in Mice J. Immunol., July 15, 2002; 169(2): 906 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mempel, C. Ronet, F. Suarez, M. Gilleron, G. Puzo, L. Van Kaer, A. Lehuen, P. Kourilsky, and G. Gachelin Natural Killer T Cells Restricted by the Monomorphic MHC Class 1b CD1d1 Molecules Behave Like Inflammatory Cells J. Immunol., January 1, 2002; 168(1): 365 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawakami, Y. Kinjo, K. Uezu, S. Yara, K. Miyagi, Y. Koguchi, T. Nakayama, M. Taniguchi, and A. Saito Monocyte Chemoattractant Protein-1-Dependent Increase of V{alpha}14 NKT Cells in Lungs and Their Roles in Th1 Response and Host Defense in Cryptococcal Infection J. Immunol., December 1, 2001; 167(11): 6525 - 6532. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Exley, N. J. Bigley, O. Cheng, S. M. A. Tahir, S. T. Smiley, Q. L. Carter, H. F. Stills, M. J. Grusby, Y. Koezuka, M. Taniguchi, et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus J. Leukoc. Biol., May 1, 2001; 69(5): 713 - 718. [Abstract] [Full Text] |
||||
![]() |
C. Ronet, M. Mempel, N. Thieblemont, A. Lehuen, P. Kourilsky, and G. Gachelin Role of the Complementarity-Determining Region 3 (CDR3) of the TCR-{{beta}} Chains Associated with the V{{alpha}}14 Semi-Invariant TCR {{alpha}}-Chain in the Selection of CD4+ NK T Cells J. Immunol., February 1, 2001; 166(3): 1755 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kumar, A. Belperron, S. W. Barthold, and L. K. Bockenstedt Cutting Edge: CD1d Deficiency Impairs Murine Host Defense Against the Spirochete, Borrelia burgdorferi J. Immunol., November 1, 2000; 165(9): 4797 - 4801. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gonzalez-Aseguinolaza, C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, et al. alpha -Galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria PNAS, July 18, 2000; 97(15): 8461 - 8466. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zeng, M.-K. Lee, J. Tung, A. Brendolan, and S. Strober Cutting Edge: A Role for CD1 in the Pathogenesis of Lupus in NZB/NZW Mice J. Immunol., May 15, 2000; 164(10): 5000 - 5004. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Spada, E. P. Grant, P. J. Peters, M. Sugita, A. Melian, D. S. Leslie, H. K. Lee, E. van Donselaar, D. A. Hanson, A. M. Krensky, et al. Self-Recognition of CD1 by {gamma}/{delta} T Cells: Implications for Innate Immunity J. Exp. Med., March 13, 2000; 191(6): 937 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hong and L. Van Kaer Immune Privilege: Keeping an Eye on Natural Killer T Cells J. Exp. Med., November 1, 1999; 190(9): 1197 - 1200. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |